Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-01-26

Clinical Trial Update: THERMOCOOL® SMARTTOUCH™ Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation [Phase 3]

View source ↗

Summary

Phase 3 trial of the THERMOCOOL SMARTTOUCH catheter for symptomatic paroxysmal atrial fibrillation has completed and posted results in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Biosense Webster, Inc. | Conditions: Heart Diseases, Arrhythmia | Phase 3 | Status: COMPLETED | Results posted: 2015-01-26